Company Information
Ask for more detail from the seller
Contact SupplierIndicated for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135 in individuals 2 months through 55 years of age.
Single dose in adults through 10 to 55 years of age.